| Model Number |
SN60WF |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Endophthalmitis (1835)
|
| Date of Event |
03/16/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
|
| |
|
Event or Problem Description
|
|
A surgeon reported that following an intraocular lens (iol) implant procedure, the patient experienced endophthalmitis during second follow up visit.The patient was treated immediately, and the patient was not fine due to other condition.Patient is diabetic.Scheduled for surgery and was referred to retina specialist as to save its remaining vision.Still for follow up.There are five medical device reports associated with this complaint.This report is 3 of 5.Additional information has been received stating patient was hospitalized, with disability, required intravitreal injection of antibiotics and evisceration to prevent permanent damage.Latest visual acuity was reported as no light perception.
|
| |
|
Additional Manufacturer Narrative
|
|
The manufacturer internal reference number is: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
The product was not returned.Product history records were reviewed, and the documentation indicated the product met release criteria.Only balanced salt solution (bss) was provided.No other associated products were provided.It is unknown if qualified products were used.The product investigation could not identify a root cause.The product was not returned and remains implanted.All iols are terminally sterilized with 100 percentage (%) ethylene oxide sterilization.Company uses an overkill sterilization approach, which greatly exceeds the minimum requirements for sterility.Critical parameters for sterilization cycles are recorded and retained for every sterilization load to demonstrate that the acceptance criteria for the sterilization process are met.Information was provided that the patient came in for the 1st follow up without symptoms of endophthalmitis, however three days later, during the second follow up, the patient showed severe endophthalmitis.It was reported the patient was treated immediately.It was provided that the patient was not fine, due to the patient's diabetes.Patient was referred to a retinal specialist.No further information has been provided at this time.Due diligence has been performed in an attempt to obtain further information on this event.File will be reopened if new information is received.The manufacturer internal reference number is: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
The manufacturer internal reference number is: (b)(4).
|
| |
|
Event or Problem Description
|
|
Additional information has been received stating patient issues were resolved and vision was same pre op and post op.
|
| |
|
Search Alerts/Recalls
|